| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CCDC69 EZR MYO1E CLIP2 CENPE SPTBN2 NUMA1 GAS8 MYO1B ACTN4 PRC1 OPA1 CEP350 SIRT2 CCDC66 LRRC27 PRKAA1 MACF1 DAAM2 TRPV4 AFDN DNAI7 TNNT3 UTRN FRMD5 HTT | 3.47e-07 | 1099 | 155 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule binding | CCDC69 EZR CLIP2 CENPE NUMA1 GAS8 PRC1 OPA1 CEP350 CCDC66 MACF1 TRPV4 DNAI7 | 8.75e-07 | 308 | 155 | 13 | GO:0008017 |
| GeneOntologyMolecularFunction | tubulin binding | CCDC69 EZR CLIP2 CENPE NUMA1 GAS8 PRC1 OPA1 CEP350 SIRT2 CCDC66 MACF1 TRPV4 DNAI7 HTT | 1.28e-06 | 428 | 155 | 15 | GO:0015631 |
| GeneOntologyMolecularFunction | histone H2BS36 kinase activity | 5.99e-05 | 2 | 155 | 2 | GO:0140823 | |
| GeneOntologyMolecularFunction | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity | 5.99e-05 | 2 | 155 | 2 | GO:0047322 | |
| GeneOntologyMolecularFunction | histone H2B kinase activity | 5.99e-05 | 2 | 155 | 2 | GO:0140998 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | EZR CNTN4 SPTBN2 TBC1D2 CASR MYO1B ACTN4 PFKP ITGB3 NRXN1 MACF1 AFDN UTRN FRMD5 | 2.45e-04 | 599 | 155 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | FLT3 MAPKAPK2 CDK11A OAS2 PFKP TRRAP MAP3K12 TIE1 CDK13 DSTYK GYS2 ETNK2 PRKAA1 PRKAA2 OASL MAP3K13 POMK IP6K2 | 3.65e-04 | 938 | 155 | 18 | GO:0016772 |
| GeneOntologyMolecularFunction | actin binding | EZR MYO1E SPTBN2 MYO1B ACTN4 LRRC27 MACF1 DAAM2 TRPV4 AFDN TNNT3 UTRN | 3.71e-04 | 479 | 155 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | 4.05e-04 | 227 | 155 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | beta-tubulin binding | 5.64e-04 | 49 | 155 | 4 | GO:0048487 | |
| GeneOntologyMolecularFunction | 2'-5'-oligoadenylate synthetase activity | 5.90e-04 | 5 | 155 | 2 | GO:0001730 | |
| GeneOntologyMolecularFunction | kinase activity | FLT3 MAPKAPK2 CDK11A PFKP TRRAP MAP3K12 TIE1 CDK13 DSTYK ETNK2 PRKAA1 PRKAA2 MAP3K13 POMK IP6K2 | 9.11e-04 | 764 | 155 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | FLT3 MAPKAPK2 CDK11A PFKP MAP3K12 TIE1 CDK13 DSTYK ETNK2 PRKAA1 PRKAA2 MAP3K13 POMK IP6K2 | 1.28e-03 | 709 | 155 | 14 | GO:0016773 |
| GeneOntologyBiologicalProcess | microtubule-based process | CCDC69 EZR CFAP91 KAT5 DNAH10 CLIP2 CENPE IFT57 ASH1L NUMA1 GAS8 CDK11A CFAP43 PRC1 ADCY3 OPA1 ANKRD53 CEP350 CCDC66 IQCA1 CEP250 TAF7L PRKAA1 SSX2IP PRKAA2 ASPM MACF1 TRPV4 DNAI7 DYNC1H1 HTT MYBL2 | 6.60e-12 | 1058 | 152 | 32 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CCDC69 EZR CFAP91 KAT5 CLIP2 CENPE NUMA1 GAS8 CDK11A CFAP43 PRC1 ANKRD53 CEP350 CCDC66 IQCA1 CEP250 PRKAA1 SSX2IP PRKAA2 ASPM TRPV4 DYNC1H1 HTT MYBL2 | 5.96e-10 | 720 | 152 | 24 | GO:0000226 |
| GeneOntologyBiologicalProcess | organelle assembly | CCDC69 EZR CFAP91 CENPE IFT57 DZIP1L SPTBN2 TBC1D2 NUMA1 GAS8 CFAP43 PRC1 CEP350 NTNG2 CCDC66 NRXN1 CEP250 PRKAA1 SSX2IP PRKAA2 ASPM TMEM41B TNNT3 DYNC1H1 HTT MYBL2 | 2.46e-07 | 1138 | 152 | 26 | GO:0070925 |
| GeneOntologyBiologicalProcess | lipid droplet disassembly | 1.34e-05 | 7 | 152 | 3 | GO:1905691 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | CFAP91 DNAH10 CENPE IFT57 ASH1L GAS8 CFAP43 ADCY3 OPA1 TAF7L SSX2IP DNAI7 DYNC1H1 HTT | 1.77e-05 | 493 | 152 | 14 | GO:0007018 |
| GeneOntologyBiologicalProcess | establishment of chromosome localization | 3.39e-05 | 122 | 152 | 7 | GO:0051303 | |
| GeneOntologyBiologicalProcess | spindle organization | 4.38e-05 | 224 | 152 | 9 | GO:0007051 | |
| GeneOntologyBiologicalProcess | chromosome localization | 5.09e-05 | 130 | 152 | 7 | GO:0050000 | |
| GeneOntologyBiologicalProcess | positive regulation of chromosome segregation | 5.83e-05 | 29 | 152 | 4 | GO:0051984 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in mitosis | 7.58e-05 | 187 | 152 | 8 | GO:1902850 | |
| GeneOntologyBiologicalProcess | positive regulation of attachment of spindle microtubules to kinetochore | 8.22e-05 | 12 | 152 | 3 | GO:0051987 | |
| GeneOntologyBiologicalProcess | cellular response to glucose stimulus | 1.05e-04 | 196 | 152 | 8 | GO:0071333 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 1.13e-04 | 313 | 152 | 10 | GO:0099173 | |
| GeneOntologyBiologicalProcess | cellular response to hexose stimulus | 1.17e-04 | 199 | 152 | 8 | GO:0071331 | |
| GeneOntologyBiologicalProcess | cellular response to monosaccharide stimulus | 1.25e-04 | 201 | 152 | 8 | GO:0071326 | |
| GeneOntologyBiologicalProcess | cytoplasmic microtubule organization | 1.27e-04 | 66 | 152 | 5 | GO:0031122 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | EZR GNL3L KAT5 CENPE SPTBN2 TBC1D2 NUMA1 CDK11A ITGB3 OPA1 ANKRD53 FCHSD2 SIRT2 NRXN1 PRKAA1 PRKAA2 FBXO7 LRP5 DAAM2 TRPV4 DYNC1H1 HTT DOC2B | 1.30e-04 | 1342 | 152 | 23 | GO:0033043 |
| GeneOntologyBiologicalProcess | positive regulation of cell maturation | 1.35e-04 | 14 | 152 | 3 | GO:1903431 | |
| GeneOntologyBiologicalProcess | spindle localization | 1.36e-04 | 67 | 152 | 5 | GO:0051653 | |
| GeneOntologyBiologicalProcess | response to glucose | 1.37e-04 | 260 | 152 | 9 | GO:0009749 | |
| GeneOntologyBiologicalProcess | spindle assembly | 1.42e-04 | 153 | 152 | 7 | GO:0051225 | |
| GeneOntologyBiologicalProcess | metaphase chromosome alignment | 1.42e-04 | 107 | 152 | 6 | GO:0051310 | |
| GeneOntologyBiologicalProcess | response to hexose | 1.58e-04 | 265 | 152 | 9 | GO:0009746 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection arborization | 1.67e-04 | 15 | 152 | 3 | GO:0150011 | |
| GeneOntologyBiologicalProcess | regulation of metaphase plate congression | 1.67e-04 | 15 | 152 | 3 | GO:0090235 | |
| GeneOntologyBiologicalProcess | neuron projection arborization | 1.72e-04 | 38 | 152 | 4 | GO:0140058 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule organizing center | 1.91e-04 | 39 | 152 | 4 | GO:1905508 | |
| GeneOntologyBiologicalProcess | response to monosaccharide | 1.92e-04 | 272 | 152 | 9 | GO:0034284 | |
| GeneOntologyBiologicalProcess | cellular response to carbohydrate stimulus | 1.99e-04 | 215 | 152 | 8 | GO:0071322 | |
| GeneOntologyBiologicalProcess | glucose homeostasis | 2.10e-04 | 338 | 152 | 10 | GO:0042593 | |
| GeneOntologyBiologicalProcess | carbohydrate homeostasis | 2.15e-04 | 339 | 152 | 10 | GO:0033500 | |
| GeneOntologyBiologicalProcess | intracellular glucose homeostasis | 2.18e-04 | 218 | 152 | 8 | GO:0001678 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 2.38e-04 | 280 | 152 | 9 | GO:1902115 | |
| GeneOntologyBiologicalProcess | positive regulation of protein acetylation | 2.95e-04 | 18 | 152 | 3 | GO:1901985 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | KAT5 CENPE NUMA1 PRC1 ANKRD53 SIRT2 ASPM TERB1 DYNC1H1 MYBL2 | 3.18e-04 | 356 | 152 | 10 | GO:0098813 |
| GeneOntologyBiologicalProcess | cortical microtubule organization | 3.21e-04 | 4 | 152 | 2 | GO:0043622 | |
| GeneOntologyBiologicalProcess | protein localization to lipid droplet | 3.21e-04 | 4 | 152 | 2 | GO:1990044 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | NUMA1 CDK11A CFAP43 ANKRD53 PRKAA1 PRKAA2 MACF1 TRPV4 DYNC1H1 | 3.32e-04 | 293 | 152 | 9 | GO:0032886 |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | KAT5 CENPE NUMA1 OPA1 ANKRD53 FCHSD2 SIRT2 FBXO7 LRP5 TRPV4 DYNC1H1 HTT DOC2B | 3.37e-04 | 574 | 152 | 13 | GO:0010638 |
| GeneOntologyBiologicalProcess | response to carbohydrate | 4.04e-04 | 301 | 152 | 9 | GO:0009743 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | EZR CFAP91 IFT57 DZIP1L TBC1D2 GAS8 CFAP43 CEP350 CCDC66 NRXN1 CEP250 SSX2IP DAAM2 HTT | 4.47e-04 | 670 | 152 | 14 | GO:0120031 |
| GeneOntologyBiologicalProcess | cilium assembly | CFAP91 IFT57 DZIP1L TBC1D2 GAS8 CFAP43 CEP350 CCDC66 CEP250 SSX2IP HTT | 4.64e-04 | 444 | 152 | 11 | GO:0060271 |
| GeneOntologyBiologicalProcess | cell projection assembly | EZR CFAP91 IFT57 DZIP1L TBC1D2 GAS8 CFAP43 CEP350 CCDC66 NRXN1 CEP250 SSX2IP DAAM2 HTT | 5.57e-04 | 685 | 152 | 14 | GO:0030031 |
| GeneOntologyBiologicalProcess | mitotic nuclear division | 5.74e-04 | 316 | 152 | 9 | GO:0140014 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | KAT5 CENPE RBBP8 NUMA1 CDK11A TRIM71 PRC1 TRRAP ANKRD53 SLFN12L SIRT2 FBXO7 LRP5 DYNC1H1 HTT MYBL2 | 5.79e-04 | 854 | 152 | 16 | GO:1903047 |
| GeneOntologyBiologicalProcess | postsynapse assembly | 6.28e-04 | 93 | 152 | 5 | GO:0099068 | |
| GeneOntologyBiologicalProcess | chromosome segregation | CCDC69 KAT5 CENPE NUMA1 PRC1 ANKRD53 SIRT2 ASPM TERB1 DYNC1H1 MYBL2 | 6.81e-04 | 465 | 152 | 11 | GO:0007059 |
| GeneOntologyBiologicalProcess | tubulin deacetylation | 7.09e-04 | 24 | 152 | 3 | GO:0090042 | |
| GeneOntologyBiologicalProcess | regulation of attachment of spindle microtubules to kinetochore | 7.09e-04 | 24 | 152 | 3 | GO:0051988 | |
| GeneOntologyBiologicalProcess | organelle localization | EZR KAT5 CENPE NUMA1 ACTN4 OPA1 ANKRD53 SIRT2 NRXN1 ASPM TERB1 KLHL12 DYNC1H1 HTT | 7.17e-04 | 703 | 152 | 14 | GO:0051640 |
| GeneOntologyBiologicalProcess | cilium movement | 7.22e-04 | 261 | 152 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 7.27e-04 | 145 | 152 | 6 | GO:0001578 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | EZR KAT5 CENPE NUMA1 ACTN4 OPA1 ANKRD53 SIRT2 TERB1 KLHL12 DYNC1H1 HTT | 7.44e-04 | 546 | 152 | 12 | GO:0051656 |
| GeneOntologyBiologicalProcess | positive regulation of aggrephagy | 7.94e-04 | 6 | 152 | 2 | GO:1905337 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | CCDC69 EZR CENPE NUMA1 PRC1 PRKAA1 PRKAA2 ASPM TNNT3 DYNC1H1 MYBL2 | 8.10e-04 | 475 | 152 | 11 | GO:0140694 |
| GeneOntologyBiologicalProcess | cilium organization | CFAP91 IFT57 DZIP1L TBC1D2 GAS8 CFAP43 CEP350 CCDC66 CEP250 SSX2IP HTT | 8.24e-04 | 476 | 152 | 11 | GO:0044782 |
| GeneOntologyCellularComponent | microtubule | DNAH10 CLIP2 CENPE NUMA1 GAS8 PRC1 OPA1 SIRT2 CCDC66 ASPM MACF1 TRPV4 DNAI7 PBXIP1 DYNC1H1 | 1.93e-05 | 533 | 163 | 15 | GO:0005874 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 6.94e-05 | 129 | 163 | 7 | GO:0030863 | |
| GeneOntologyCellularComponent | cytoplasmic region | CFAP91 DNAH10 IFT57 DZIP1L NUMA1 GAS8 CFAP43 OPA1 DNAI7 DYNC1H1 HTT | 1.26e-04 | 360 | 163 | 11 | GO:0099568 |
| GeneOntologyCellularComponent | cell cortex | EZR MYO1E CLIP2 SPTBN2 NUMA1 ACTN4 GYS2 MACF1 TRPV4 DYNC1H1 PDZD4 | 1.64e-04 | 371 | 163 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | CFAP91 DNAH10 IFT57 DZIP1L GAS8 CFAP43 OPA1 DNAI7 DYNC1H1 HTT | 1.99e-04 | 317 | 163 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | apical part of cell | EZR SPTBN2 NUMA1 ANO1 CASR MYO1B ITGB3 LZTS1 DSTYK PRKAA1 PRKAA2 ASPM TRPV4 AFDN | 2.31e-04 | 592 | 163 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | mitotic spindle midzone | 2.42e-04 | 16 | 163 | 3 | GO:1990023 | |
| GeneOntologyCellularComponent | spindle midzone | 2.62e-04 | 40 | 163 | 4 | GO:0051233 | |
| GeneOntologyCellularComponent | supramolecular fiber | LRRC39 EZR DNAH10 CLIP2 CENPE NUMA1 GAS8 MYO1B ACTN4 PRC1 OPA1 SIRT2 CCDC66 LRRC27 ASPM MACF1 TRPV4 DNAI7 TNNT3 PBXIP1 DYNC1H1 | 3.45e-04 | 1179 | 163 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | LRRC39 EZR DNAH10 CLIP2 CENPE NUMA1 GAS8 MYO1B ACTN4 PRC1 OPA1 SIRT2 CCDC66 LRRC27 ASPM MACF1 TRPV4 DNAI7 TNNT3 PBXIP1 DYNC1H1 | 3.77e-04 | 1187 | 163 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | filopodium | 4.11e-04 | 123 | 163 | 6 | GO:0030175 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | EZR DNAH10 CLIP2 CENPE NUMA1 GAS8 MYO1B PRC1 OPA1 SIRT2 CCDC66 ASPM MACF1 TRPV4 DNAI7 PBXIP1 DYNC1H1 | 6.74e-04 | 899 | 163 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 8.11e-04 | 93 | 163 | 5 | GO:0030864 | |
| GeneOntologyCellularComponent | ciliary basal body | 8.64e-04 | 195 | 163 | 7 | GO:0036064 | |
| GeneOntologyCellularComponent | axoneme | 1.22e-03 | 207 | 163 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | microtubule minus-end | 1.24e-03 | 7 | 163 | 2 | GO:0036449 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.26e-03 | 208 | 163 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | actin-based cell projection | 1.56e-03 | 278 | 163 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | apical plasma membrane | EZR SPTBN2 ANO1 CASR ITGB3 LZTS1 DSTYK PRKAA1 PRKAA2 ASPM TRPV4 | 1.57e-03 | 487 | 163 | 11 | GO:0016324 |
| GeneOntologyCellularComponent | ruffle membrane | 1.58e-03 | 108 | 163 | 5 | GO:0032587 | |
| GeneOntologyCellularComponent | cilium | EZR CFAP91 SPATA19 DNAH10 IFT57 DZIP1L GAS8 CFAP43 ADCY3 CCDC66 IQCA1 CCDC34 CEP250 SSX2IP TRPV4 DNAI7 | 1.80e-03 | 898 | 163 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | nuclear speck | PRPF6 CWC25 ERBIN CDK13 PRKAA1 PRKAA2 AFDN ASCC3 SMURF2 MOCS2 | 2.10e-03 | 431 | 163 | 10 | GO:0016607 |
| GeneOntologyCellularComponent | microtubule organizing center | EZR IFT57 MAPKAPK2 DZIP1L NUMA1 GAS8 CEP350 SIRT2 CCDC66 CEP250 SSX2IP ASPM KLHL12 DYNC1H1 CYTH4 HTT | 2.26e-03 | 919 | 163 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | cell-cell junction | EZR MYO1E SPTBN2 ASH1L ACTN4 ITGB3 SIRT2 NRXN1 SSX2IP TRPV4 AFDN FRMD5 | 2.36e-03 | 591 | 163 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | inner dynein arm | 2.61e-03 | 10 | 163 | 2 | GO:0036156 | |
| Domain | DUF1220 | 1.55e-06 | 11 | 158 | 4 | PF06758 | |
| Domain | NBPF_dom | 1.55e-06 | 11 | 158 | 4 | IPR010630 | |
| Domain | NBPF | 1.55e-06 | 11 | 158 | 4 | PS51316 | |
| Domain | Spectrin | 3.85e-05 | 23 | 158 | 4 | PF00435 | |
| Domain | ACTININ_2 | 3.85e-05 | 23 | 158 | 4 | PS00020 | |
| Domain | ACTININ_1 | 3.85e-05 | 23 | 158 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.85e-05 | 23 | 158 | 4 | IPR001589 | |
| Domain | DUF1220 | 4.81e-05 | 9 | 158 | 3 | SM01148 | |
| Domain | MAP3K12_MAP3K13 | 7.11e-05 | 2 | 158 | 2 | IPR017419 | |
| Domain | AdenylateSensor | 7.11e-05 | 2 | 158 | 2 | PF16579 | |
| Domain | AMPK_C | 7.11e-05 | 2 | 158 | 2 | IPR032270 | |
| Domain | Spectrin_repeat | 9.93e-05 | 29 | 158 | 4 | IPR002017 | |
| Domain | SPEC | 1.47e-04 | 32 | 158 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.47e-04 | 32 | 158 | 4 | IPR018159 | |
| Domain | ATPase_dyneun-rel_AAA | 2.02e-04 | 14 | 158 | 3 | IPR011704 | |
| Domain | AAA_5 | 2.02e-04 | 14 | 158 | 3 | PF07728 | |
| Domain | Kinase-like_dom | FLT3 MAPKAPK2 CDK11A TRRAP MAP3K12 TIE1 CDK13 DSTYK ETNK2 PRKAA1 PRKAA2 MACF1 MAP3K13 POMK | 2.12e-04 | 542 | 158 | 14 | IPR011009 |
| Domain | CH | 2.23e-04 | 65 | 158 | 5 | SM00033 | |
| Domain | CH | 3.16e-04 | 70 | 158 | 5 | PF00307 | |
| Domain | - | 3.38e-04 | 71 | 158 | 5 | 1.10.418.10 | |
| Domain | CH | 3.84e-04 | 73 | 158 | 5 | PS50021 | |
| Domain | OAS1_C | 4.22e-04 | 4 | 158 | 2 | PF10421 | |
| Domain | 2-5-oligoadenylate_synth_CS | 4.22e-04 | 4 | 158 | 2 | IPR006117 | |
| Domain | 25A_SYNTH_3 | 4.22e-04 | 4 | 158 | 2 | PS50152 | |
| Domain | 2-5-oligoAdlate_synth_1_dom2/C | 4.22e-04 | 4 | 158 | 2 | IPR018952 | |
| Domain | 2-5A_synthase | 4.22e-04 | 4 | 158 | 2 | IPR026774 | |
| Domain | - | 4.22e-04 | 4 | 158 | 2 | 1.10.1410.20 | |
| Domain | 25A_SYNTH_1 | 4.22e-04 | 4 | 158 | 2 | PS00832 | |
| Domain | 25A_SYNTH_2 | 4.22e-04 | 4 | 158 | 2 | PS00833 | |
| Domain | CH-domain | 4.36e-04 | 75 | 158 | 5 | IPR001715 | |
| Domain | ARM-like | 4.97e-04 | 270 | 158 | 9 | IPR011989 | |
| Domain | - | 6.15e-04 | 222 | 158 | 8 | 1.25.10.10 | |
| Domain | 2-5-oligoadenylate_synth_N | 6.99e-04 | 5 | 158 | 2 | IPR006116 | |
| Domain | EGF | 7.12e-04 | 126 | 158 | 6 | PF00008 | |
| Domain | Pkinase_Tyr | 8.06e-04 | 129 | 158 | 6 | PF07714 | |
| Domain | E1_dh | 1.04e-03 | 6 | 158 | 2 | PF00676 | |
| Domain | DH_E1 | 1.04e-03 | 6 | 158 | 2 | IPR001017 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.14e-03 | 138 | 158 | 6 | IPR001245 | |
| Domain | KA1/Ssp2_C | 1.45e-03 | 7 | 158 | 2 | IPR028375 | |
| Domain | Myosin_TH1 | 1.45e-03 | 7 | 158 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 1.45e-03 | 7 | 158 | 2 | IPR010926 | |
| Domain | TH1 | 1.45e-03 | 7 | 158 | 2 | PS51757 | |
| Domain | DHC_N1 | 1.93e-03 | 8 | 158 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.93e-03 | 8 | 158 | 2 | IPR013594 | |
| Domain | ARM-type_fold | 2.42e-03 | 339 | 158 | 9 | IPR016024 | |
| Domain | AAA | 2.93e-03 | 34 | 158 | 3 | PS00674 | |
| Domain | Prot_kinase_dom | FLT3 MAPKAPK2 CDK11A MAP3K12 TIE1 CDK13 DSTYK PRKAA1 PRKAA2 MAP3K13 POMK | 3.02e-03 | 489 | 158 | 11 | IPR000719 |
| Domain | MIF4G | 3.06e-03 | 10 | 158 | 2 | SM00543 | |
| Domain | CAP_GLY | 3.06e-03 | 10 | 158 | 2 | PF01302 | |
| Domain | MIF4G | 3.06e-03 | 10 | 158 | 2 | PF02854 | |
| Domain | CAP_GLY | 3.06e-03 | 10 | 158 | 2 | SM01052 | |
| Domain | - | 3.06e-03 | 10 | 158 | 2 | 2.30.30.190 | |
| Domain | MIF4G-like_typ-3 | 3.06e-03 | 10 | 158 | 2 | IPR003890 | |
| Domain | CAP_GLY_1 | 3.06e-03 | 10 | 158 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 3.06e-03 | 10 | 158 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 3.06e-03 | 10 | 158 | 2 | IPR000938 | |
| Domain | PROTEIN_KINASE_DOM | FLT3 MAPKAPK2 CDK11A MAP3K12 TIE1 CDK13 DSTYK PRKAA1 PRKAA2 MAP3K13 POMK | 3.21e-03 | 493 | 158 | 11 | PS50011 |
| Domain | THDP-binding | 5.22e-03 | 13 | 158 | 2 | IPR029061 | |
| Domain | - | 5.22e-03 | 13 | 158 | 2 | 3.40.50.970 | |
| Domain | P-loop_NTPase | GNL3L SAMD9 DNAH10 MYO1E CENPE VWA8 NDST4 MYO1B ATAD2 OPA1 FBH1 IQCA1 ASPM ASCC3 DYNC1H1 | 5.60e-03 | 848 | 158 | 15 | IPR027417 |
| Domain | PROTEIN_KINASE_ATP | FLT3 MAPKAPK2 CDK11A MAP3K12 TIE1 CDK13 DSTYK PRKAA1 PRKAA2 MAP3K13 | 5.77e-03 | 459 | 158 | 10 | PS00107 |
| Domain | Dynein_heavy_chain_D4_dom | 6.05e-03 | 14 | 158 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.05e-03 | 14 | 158 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.05e-03 | 14 | 158 | 2 | IPR013602 | |
| Domain | DHC_N2 | 6.05e-03 | 14 | 158 | 2 | PF08393 | |
| Domain | - | 6.05e-03 | 14 | 158 | 2 | 3.10.20.30 | |
| Domain | Beta-grasp_dom | 6.05e-03 | 14 | 158 | 2 | IPR012675 | |
| Domain | MT | 6.05e-03 | 14 | 158 | 2 | PF12777 | |
| Domain | AAA_8 | 6.05e-03 | 14 | 158 | 2 | PF12780 | |
| Domain | DHC_fam | 6.95e-03 | 15 | 158 | 2 | IPR026983 | |
| Domain | - | 6.95e-03 | 15 | 158 | 2 | 1.25.40.180 | |
| Domain | Dynein_heavy | 6.95e-03 | 15 | 158 | 2 | PF03028 | |
| Domain | MIF4-like | 6.95e-03 | 15 | 158 | 2 | IPR016021 | |
| Domain | Dynein_heavy_dom | 6.95e-03 | 15 | 158 | 2 | IPR004273 | |
| Domain | IQ_motif_EF-hand-BS | 7.17e-03 | 90 | 158 | 4 | IPR000048 | |
| Domain | AAA | 7.63e-03 | 144 | 158 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 7.63e-03 | 144 | 158 | 5 | IPR003593 | |
| Domain | IQ | 8.04e-03 | 93 | 158 | 4 | PS50096 | |
| Pubmed | 6.20e-12 | 21 | 169 | 7 | 16079250 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | GALNT10 MIA3 GNL3L MAPKAPK2 ASH1L MACROD1 OGDH TRRAP ERBIN MAP3K12 ADCY3 JMJD1C CASZ1 ITFG1 SH3BP4 PTPRN2 CDK13 LRRC27 PRKAA2 OSBPL9 ANKRD11 LRP5 MACF1 PHF14 UTRN SMURF2 CRAMP1 GOLGA4 HTT | 1.74e-10 | 1489 | 169 | 29 | 28611215 |
| Pubmed | CNTN4 DMXL2 CLIP2 SPTBN2 JMJD1C CASZ1 CEP350 CDK13 DSTYK SSX2IP MACF1 PHF14 MINAR1 TMEM41B MGA PDZRN4 | 2.91e-09 | 493 | 169 | 16 | 15368895 | |
| Pubmed | SPTBN2 NUMA1 NCBP1 MYO1B ACTN4 PRPF6 PFKP TEX10 ATAD2 TRRAP UBTF OASL MACF1 AFDN ASCC3 UTRN DYNC1H1 FTSJ3 | 3.71e-09 | 653 | 169 | 18 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EZR SPTBN2 NUMA1 NCBP1 MYO1B ACTN4 PRPF6 PFKP TEX10 TRRAP CEP350 UBTF PRKAA1 MACF1 AFDN ASCC3 MGA UTRN TARS1 DYNC1H1 FTSJ3 | 3.06e-08 | 1024 | 169 | 21 | 24711643 |
| Pubmed | EZR CNTN4 DMXL2 MIA3 CLIP2 CENPE SPTBN2 NUMA1 TEX10 ERBIN OPA1 NRXN1 PTPRN2 LZTS1 NCAN MACF1 AFDN MGA DYNC1H1 GOLGA4 | 5.46e-08 | 963 | 169 | 20 | 28671696 | |
| Pubmed | 9.31e-08 | 76 | 169 | 7 | 27542412 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 1.10e-07 | 10 | 169 | 4 | 22973535 | |
| Pubmed | Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's disease. | 1.13e-07 | 3 | 169 | 3 | 21768291 | |
| Pubmed | CASP8AP2 DMXL2 MIA3 VWA8 SPTBN2 BCKDHA PRPF6 PFKP OGDH ERBIN SH3BP4 LIFR UBTF SSX2IP ASPM ANKRD11 MACF1 ASCC3 GOLGA5 PBXIP1 TARS1 GOLGA4 XPR1 FTSJ3 | 2.57e-07 | 1487 | 169 | 24 | 33957083 | |
| Pubmed | EZR CNTN4 DMXL2 CFAP91 MYO1E CLIP2 SPTBN2 ASH1L NCBP1 ACTN4 CEP350 FBH1 FBXO7 MACF1 DAAM2 AFDN DNAI7 UTRN SMURF2 PBXIP1 TARS1 DYNC1H1 | 3.19e-07 | 1285 | 169 | 22 | 35914814 | |
| Pubmed | 5.43e-07 | 33 | 169 | 5 | 26025364 | ||
| Pubmed | GARIN5B EZR EFCAB5 RBBP8 DZIP1L SPTBN2 ASH1L NUMA1 NCBP1 MYO1B ACTN4 PRPF6 PFKP TEX10 OGDH ERBIN NRXN1 CDK13 ASPM MACF1 PHF14 TOP1MT SMURF2 | 5.75e-07 | 1442 | 169 | 23 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GNL3L NUMA1 MYO1B ACTN4 PRPF6 PFKP TEX10 ATAD2 TRRAP ERBIN UPF2 UBTF ASPM MACF1 AFDN ASCC3 MGA UTRN TARS1 DYNC1H1 GOLGA4 FTSJ3 | 7.55e-07 | 1353 | 169 | 22 | 29467282 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CENPE NUMA1 NCBP1 BCKDHA PRPF6 PRC1 TEX10 OGDH TRRAP UPF2 CDK13 UBTF ASPM MACF1 ASCC3 FTSJ3 | 1.04e-06 | 759 | 169 | 16 | 35915203 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | GNL3L CENPE SPTBN2 NUMA1 CDK11A PRPF6 TEX10 TRRAP OPA1 UBTF ANKRD11 DNAI7 ASCC3 | 1.08e-06 | 497 | 169 | 13 | 36774506 |
| Pubmed | CLIP2 BCKDHA ACTN4 ERBIN LIFR PTPRN2 CEP250 NCAN MACF1 SERAC1 MAP3K13 PBXIP1 | 1.45e-06 | 430 | 169 | 12 | 32581705 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO1E VWA8 MAPKAPK2 CFAP43 TRRAP CASZ1 SH3BP4 SIRT2 ADAMTS7 CDK13 CCDC34 ANKRD11 LRP5 SMURF2 CRAMP1 DYNC1H1 CYTH4 HTT MYBL2 | 2.03e-06 | 1105 | 169 | 19 | 35748872 |
| Pubmed | Choline kinase alpha 2 acts as a protein kinase to promote lipolysis of lipid droplets. | 2.23e-06 | 6 | 169 | 3 | 34077757 | |
| Pubmed | Activation of Mevalonate Pathway via LKB1 Is Essential for Stability of Treg Cells. | 2.23e-06 | 6 | 169 | 3 | 31167140 | |
| Pubmed | 2.38e-06 | 234 | 169 | 9 | 36243803 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EZR GNL3L SAMD9 MYO1E SPTBN2 NUMA1 NCBP1 MYO1B ACTN4 PRPF6 PFKP PRC1 TEX10 UPF2 UBTF OASL ASCC3 TARS1 DYNC1H1 FTSJ3 | 3.47e-06 | 1257 | 169 | 20 | 36526897 |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 28621313 | ||
| Pubmed | MIA3 IFT57 SPTBN2 NCBP1 MYO1B BCKDHA ACTN4 TEX10 ERBIN OPA1 CEP350 PTPRN2 UBTF SSX2IP GOLGA5 UTRN GOLGA4 FTSJ3 | 3.95e-06 | 1049 | 169 | 18 | 27880917 | |
| Pubmed | 4.21e-06 | 251 | 169 | 9 | 29778605 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EZR GNL3L MYO1E SPTBN2 NUMA1 CDK11A MYO1B ACTN4 PRPF6 PFKP PRC1 TEX10 CDK13 UBTF TOP1MT DYNC1H1 FTSJ3 | 4.24e-06 | 949 | 169 | 17 | 36574265 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EZR MIA3 GNL3L SPTBN2 NUMA1 ACTN4 PRPF6 PFKP PRC1 UBE2T UPF2 CEP250 LRP5 MACF1 UTRN DYNC1H1 | 4.24e-06 | 847 | 169 | 16 | 35235311 |
| Pubmed | 4.69e-06 | 191 | 169 | 8 | 33762435 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | EZR DMXL2 KAT5 VWA8 SPTBN2 NCBP1 MYO1B TRIM71 PRPF6 TEX10 OGDH TRRAP OPA1 NRXN1 UPF2 MACF1 PBXIP1 DYNC1H1 | 6.04e-06 | 1082 | 169 | 18 | 38697112 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SPATA19 RBBP8 TBC1D2 NUMA1 CDK11A PFKP ATAD2 TRRAP ERBIN CDK13 AFDN PHF14 GOLGA4 CYTH4 MYBL2 | 6.33e-06 | 774 | 169 | 15 | 15302935 |
| Pubmed | DMXL2 MYO1E CLIP2 SPTBN2 ACTN4 PFKP OGDH ERBIN OPA1 SIRT2 UPF2 LZTS1 NCAN PRKAA1 OSBPL9 MACF1 AFDN UTRN PBXIP1 TARS1 DYNC1H1 | 6.75e-06 | 1431 | 169 | 21 | 37142655 | |
| Pubmed | 6.89e-06 | 339 | 169 | 10 | 30415952 | ||
| Pubmed | ASH1L TEX10 ERBIN CDK13 CEP250 LRP5 MACF1 AFDN ASCC3 MGA UTRN SMURF2 DYNC1H1 | 7.09e-06 | 591 | 169 | 13 | 15231748 | |
| Pubmed | 9.07e-06 | 209 | 169 | 8 | 36779422 | ||
| Pubmed | Development of the Olfactory Epithelium and Nasal Glands in TMEM16A-/- and TMEM16A+/+ Mice. | 9.27e-06 | 9 | 169 | 3 | 26067252 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EZR MIA3 ASH1L NUMA1 MACROD1 NCBP1 MYO1B ACTN4 PFKP OGDH MACF1 DAAM2 UTRN TARS1 DYNC1H1 | 1.04e-05 | 807 | 169 | 15 | 30575818 |
| Pubmed | 1.30e-05 | 105 | 169 | 6 | 9628581 | ||
| Pubmed | Homeostatic control of metabolic and functional fitness of Treg cells by LKB1 signalling. | 1.32e-05 | 10 | 169 | 3 | 28847007 | |
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 22027834 | ||
| Pubmed | 1.54e-05 | 64 | 169 | 5 | 26511642 | ||
| Pubmed | 1.55e-05 | 225 | 169 | 8 | 12168954 | ||
| Pubmed | EZR SPTBN2 NUMA1 TRRAP ERBIN JMJD1C OSBPL9 AFDN ASCC3 MGA DYNC1H1 HTT | 1.71e-05 | 549 | 169 | 12 | 38280479 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.73e-05 | 377 | 169 | 10 | 38117590 | |
| Pubmed | DMXL2 MIA3 GNL3L SAMD9 ITGB3 JMJD1C SH3BP4 UPF2 CDK13 DSTYK PRKAA1 AFDN PBXIP1 | 1.93e-05 | 650 | 169 | 13 | 38777146 | |
| Pubmed | 2.08e-05 | 114 | 169 | 6 | 21150319 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EZR GNL3L DNAH10 NUMA1 NCBP1 MYO1B NIPSNAP3A ACTN4 PRPF6 PRC1 ATAD2 OGDH OPA1 UBTF PRKAA2 AFDN TARS1 DYNC1H1 GOLGA4 FTSJ3 | 2.15e-05 | 1425 | 169 | 20 | 30948266 |
| Pubmed | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. | 2.23e-05 | 34 | 169 | 4 | 25925205 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 21673972 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18801964 | ||
| Pubmed | Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease. | 2.35e-05 | 2 | 169 | 2 | 34233199 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 21947382 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 32839348 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 20465544 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24328427 | ||
| Pubmed | Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase. | 2.35e-05 | 2 | 169 | 2 | 19236843 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23905686 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 15265687 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 32504885 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 31540695 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28951460 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 27600021 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23486478 | ||
| Pubmed | Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. | 2.35e-05 | 2 | 169 | 2 | 15878932 | |
| Pubmed | AMPK activation regulates neuronal structure in developing hippocampal neurons. | 2.35e-05 | 2 | 169 | 2 | 24295634 | |
| Pubmed | TRPV4 heats up ANO1-dependent exocrine gland fluid secretion. | 2.35e-05 | 2 | 169 | 2 | 29187363 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22763120 | ||
| Pubmed | AMP-activated protein kinase phosphorylates and inactivates liver glycogen synthase. | 2.35e-05 | 2 | 169 | 2 | 22233421 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 26843621 | ||
| Pubmed | Modulation of water efflux through functional interaction between TRPV4 and TMEM16A/anoctamin 1. | 2.35e-05 | 2 | 169 | 2 | 24509911 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 21209024 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24855056 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 26419588 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28974562 | ||
| Pubmed | Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. | 2.35e-05 | 2 | 169 | 2 | 12546688 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12788940 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 38019084 | ||
| Pubmed | The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma. | 2.35e-05 | 2 | 169 | 2 | 34347929 | |
| Pubmed | Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK. | 2.35e-05 | 2 | 169 | 2 | 31693892 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 9353328 | ||
| Pubmed | Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer's model mice. | 2.35e-05 | 2 | 169 | 2 | 32213711 | |
| Pubmed | AMPK knockdown in placental trophoblast cells results in altered morphology and function. | 2.35e-05 | 2 | 169 | 2 | 25003940 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 29928235 | ||
| Pubmed | [AMPK as a Metabolic Intersection between Diet and Physical Exercise]. | 2.35e-05 | 2 | 169 | 2 | 30270274 | |
| Pubmed | AMPK regulates circadian rhythms in a tissue- and isoform-specific manner. | 2.35e-05 | 2 | 169 | 2 | 21483791 | |
| Pubmed | AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. | 2.35e-05 | 2 | 169 | 2 | 20399918 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 34767944 | ||
| Pubmed | Involvement of AMPK in regulating slow-twitch muscle atrophy during hindlimb unloading in mice. | 2.35e-05 | 2 | 169 | 2 | 26244519 | |
| Pubmed | Cutting edge: Natural helper cells derive from lymphoid progenitors. | 2.35e-05 | 2 | 169 | 2 | 22025549 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12091379 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24665903 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 20830737 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22119190 | ||
| Pubmed | Role of a novel coiled-coil domain-containing protein CCDC69 in regulating central spindle assembly. | 2.35e-05 | 2 | 169 | 2 | 20962590 | |
| Pubmed | Protein expression alteration in hippocampus upon genetic repression of AMPKα isoforms. | 2.35e-05 | 2 | 169 | 2 | 33492732 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 29038293 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 21432774 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 37563583 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16186119 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 26268732 | ||
| Pubmed | Mitotic motor CENP-E cooperates with PRC1 in temporal control of central spindle assembly. | 2.35e-05 | 2 | 169 | 2 | 31174204 | |
| Interaction | DSCR9 interactions | 3.84e-06 | 147 | 167 | 9 | int:DSCR9 | |
| Interaction | ATOH1 interactions | 4.52e-06 | 80 | 167 | 7 | int:ATOH1 | |
| Interaction | H2BC6 interactions | 1.24e-05 | 62 | 167 | 6 | int:H2BC6 | |
| Cytoband | 1q21.1 | 3.48e-06 | 62 | 169 | 5 | 1q21.1 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.84e-13 | 23 | 103 | 8 | 662 | |
| GeneFamily | Myosins, class I | 8.80e-04 | 8 | 103 | 2 | 1097 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | CCDC91 MYO1E MYO1B ACTN4 LRRC2 ERBIN PLA2R1 FCHSD2 ANKRD11 MACF1 UTRN | 1.25e-07 | 212 | 167 | 11 | M39221 |
| Coexpression | DE_YY1_TARGETS_DN | 2.25e-06 | 93 | 167 | 7 | M3278 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN | 5.13e-06 | 197 | 167 | 9 | M5210 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 5.57e-06 | 199 | 167 | 9 | M5893 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP | SPTBN2 TBC1D2 NIPSNAP3A CWC25 OGDH SLFN12L MPZL2 IP6K2 DOC2B | 5.80e-06 | 200 | 167 | 9 | M7299 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | CCDC91 DMXL2 FLT3 MIA3 GNL3L NUMA1 PRPF6 TEX10 ERBIN OPA1 SH3BP4 CEP350 UPF2 CDK13 UBTF OSBPL9 MACF1 ASCC3 SMURF2 PBXIP1 DYNC1H1 GOLGA4 | 1.01e-05 | 1215 | 167 | 22 | M41122 |
| Coexpression | WHITEFORD_PEDIATRIC_CANCER_MARKERS | 1.03e-05 | 117 | 167 | 7 | M7854 | |
| Coexpression | BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP | 5.36e-05 | 12 | 167 | 3 | M34000 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_2 | 5.63e-05 | 33 | 167 | 4 | M17333 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SAMD9 ASH1L OAS2 JMJD1C CEP350 CDK13 OASL ANKRD11 MACF1 UTRN DYNC1H1 GOLGA4 | 1.76e-11 | 200 | 169 | 12 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MIA3 ASH1L NRXN1 PTPRN2 ANKRD11 MACF1 ASCC3 MGA DYNC1H1 GOLGA4 | 4.08e-09 | 195 | 169 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MIA3 ASH1L NRXN1 PTPRN2 ANKRD11 MACF1 ASCC3 MGA DYNC1H1 GOLGA4 | 4.08e-09 | 195 | 169 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-08 | 177 | 169 | 9 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-08 | 177 | 169 | 9 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.02e-08 | 198 | 169 | 9 | 085ba270f9defbf5ef45108c6d870e1d7c428479 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 4.92e-07 | 182 | 169 | 8 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-07 | 184 | 169 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 5.35e-07 | 184 | 169 | 8 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 5.35e-07 | 184 | 169 | 8 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-07 | 184 | 169 | 8 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-07 | 185 | 169 | 8 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-07 | 185 | 169 | 8 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-07 | 187 | 169 | 8 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-07 | 187 | 169 | 8 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 6.29e-07 | 188 | 169 | 8 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-07 | 192 | 169 | 8 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.29e-07 | 195 | 169 | 8 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.29e-07 | 195 | 169 | 8 | 5790b47b0e028e49b99bda8d6d9e80ac79208cdf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.62e-07 | 196 | 169 | 8 | de70cc301a8cbaedb0a5ea4a6442dcdaa477822d | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.62e-07 | 196 | 169 | 8 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 8.62e-07 | 196 | 169 | 8 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 8.95e-07 | 197 | 169 | 8 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 8.95e-07 | 197 | 169 | 8 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | distal-3-Hematologic-Proliferating_NK/T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.30e-07 | 198 | 169 | 8 | aa23119d73554733981df474648e59918d04edfc | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.30e-07 | 198 | 169 | 8 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 9.30e-07 | 198 | 169 | 8 | 47d572b9db2843aeb2079f33a852babf67270be4 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.30e-07 | 198 | 169 | 8 | bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 9.30e-07 | 198 | 169 | 8 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.30e-07 | 198 | 169 | 8 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.30e-07 | 198 | 169 | 8 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | Caecum-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 9.30e-07 | 198 | 169 | 8 | d2def132f3efe9305a5501a96ec82efb1f02c3f7 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.30e-07 | 198 | 169 | 8 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.66e-07 | 199 | 169 | 8 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 9.66e-07 | 199 | 169 | 8 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 9.66e-07 | 199 | 169 | 8 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | 9.66e-07 | 199 | 169 | 8 | ddae7fe7633661f15d3c79f5187415ffbfecce67 | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 9.66e-07 | 199 | 169 | 8 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | 9.66e-07 | 199 | 169 | 8 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.66e-07 | 199 | 169 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.66e-07 | 199 | 169 | 8 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.66e-07 | 199 | 169 | 8 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 9.66e-07 | 199 | 169 | 8 | a0c20b97cb38e493b47a06e9501fc165a78c61b2 | |
| ToppCell | COVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class | 9.66e-07 | 199 | 169 | 8 | c608d953b852b67a4e36bd63d45f0deec3eefbd9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.66e-07 | 199 | 169 | 8 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.66e-07 | 199 | 169 | 8 | c7c501ad144ac5488d0b0496554d46616f2e01a6 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.00e-06 | 200 | 169 | 8 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 1.00e-06 | 200 | 169 | 8 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.00e-06 | 200 | 169 | 8 | a1ef1b4824b2d56f6b2af15d698f58fc5590c392 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-06 | 200 | 169 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.00e-06 | 200 | 169 | 8 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class | 1.00e-06 | 200 | 169 | 8 | 0892603e604c2a945dd720685d45970f855bd5d3 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.00e-06 | 200 | 169 | 8 | 9c2095dcf70f1288d55d0ff4a97efd4fd8d0c9ee | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 1.00e-06 | 200 | 169 | 8 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-06 | 200 | 169 | 8 | 562309f9ca4a73cea5ed1d85b516891545f3ae5f | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 1.00e-06 | 200 | 169 | 8 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-06 | 200 | 169 | 8 | 83cc5f7e812896d97950afbc6bdc10c4eb2f507a | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.00e-06 | 200 | 169 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 154 | 169 | 7 | d76fd51a4587decbfe1dde1c8a9b880c5fa18e4a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 154 | 169 | 7 | b6e982e341c6cfb6ff80a318078fcb10c36d182f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.03e-06 | 163 | 169 | 7 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.42e-06 | 166 | 169 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.56e-06 | 167 | 169 | 7 | 9280558baddea51aae47f3383d895a9b0c6749a4 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-06 | 168 | 169 | 7 | 9b8a74abb83c64f0b5829dcb4275f722c82b45dc | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-06 | 168 | 169 | 7 | 4b152b8d0f4a66faf664dfacb7914b18d60ce64a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-06 | 168 | 169 | 7 | c3169ad8f4130ef18777ed86770bb722ffb5db85 | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.85e-06 | 169 | 169 | 7 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | URO-Lymphocyte-B-Plasmablast|URO / Disease, Lineage and Cell Type | 4.32e-06 | 172 | 169 | 7 | 48888ef50ac784b38aca81da68f8a94ce09c670d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-06 | 172 | 169 | 7 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.67e-06 | 174 | 169 | 7 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-06 | 174 | 169 | 7 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.67e-06 | 174 | 169 | 7 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.84e-06 | 175 | 169 | 7 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.22e-06 | 177 | 169 | 7 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.22e-06 | 177 | 169 | 7 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.22e-06 | 177 | 169 | 7 | cbedac0bddb8fc330a464815c905928c553b0fc0 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 5.22e-06 | 177 | 169 | 7 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.22e-06 | 177 | 169 | 7 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.22e-06 | 177 | 169 | 7 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.42e-06 | 178 | 169 | 7 | 04bfecf5ea5d85c843e48d08718b5d69e7bf834e | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 5.42e-06 | 178 | 169 | 7 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.04e-06 | 181 | 169 | 7 | be4f35c9eb5b3083acb2264128f095fac1f3da45 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 6.04e-06 | 181 | 169 | 7 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.27e-06 | 182 | 169 | 7 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 6.27e-06 | 182 | 169 | 7 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 119 | 169 | 6 | c3f1223356e7f245a460ea5568a223e34e458dc1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.50e-06 | 183 | 169 | 7 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.50e-06 | 183 | 169 | 7 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 6.50e-06 | 183 | 169 | 7 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.50e-06 | 183 | 169 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 6.50e-06 | 183 | 169 | 7 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.73e-06 | 184 | 169 | 7 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.73e-06 | 184 | 169 | 7 | 8260e688ec42a1374727bc85dceb7edd19a8b662 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.73e-06 | 184 | 169 | 7 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 6.97e-06 | 185 | 169 | 7 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 6.97e-06 | 185 | 169 | 7 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | COVID-cycling|COVID / Condition, Cell_class and T cell subcluster | 6.97e-06 | 185 | 169 | 7 | 5112f966735fa48f0606adcfd5c0212ad5d3d77a | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 6.97e-06 | 185 | 169 | 7 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-06 | 186 | 169 | 7 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.22e-06 | 186 | 169 | 7 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.45e-06 | 49 | 96 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.89e-05 | 50 | 96 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Disease | Intellectual Disability | ASH1L UROC1 TRRAP PTCHD1 NTNG2 METTL5 NRXN1 MACF1 SERAC1 ASCC3 DYNC1H1 HTT | 4.97e-06 | 447 | 156 | 12 | C3714756 |
| Disease | reticulocyte measurement | CCDC91 KAT5 DNAH10 VWA8 ASH1L MACROD1 HEMGN MYO1B ACTN4 ADCY3 JMJD1C SLFN12L PRKAA1 LRP5 AFDN NYAP1 ARHGAP45 MYBL2 | 1.25e-05 | 1053 | 156 | 18 | EFO_0010700 |
| Disease | spermatogenic failure (implicated_via_orthology) | 2.78e-05 | 2 | 156 | 2 | DOID:0111910 (implicated_via_orthology) | |
| Disease | body fat percentage | DMXL2 SPATA19 DNAH10 TEX10 ADCY3 NTNG2 NRXN1 UBTF MACF1 HTT PDZRN4 | 6.12e-05 | 488 | 156 | 11 | EFO_0007800 |
| Disease | Abnormal behavior | 7.72e-05 | 16 | 156 | 3 | C0233514 | |
| Disease | Prostatic Neoplasms | EZR RAG1 SAMD9 TBC1D2 ASH1L NDST4 ITGB3 CASZ1 LIFR LZTS1 MGA GOLGA4 | 1.13e-04 | 616 | 156 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | EZR RAG1 SAMD9 TBC1D2 ASH1L NDST4 ITGB3 CASZ1 LIFR LZTS1 MGA GOLGA4 | 1.13e-04 | 616 | 156 | 12 | C0376358 |
| Disease | squamous cell carcinoma | 4.45e-04 | 67 | 156 | 4 | EFO_0000707 | |
| Disease | Microcephaly | 4.45e-04 | 67 | 156 | 4 | C0025958 | |
| Disease | reticulocyte count | CCDC91 KAT5 DNAH10 VWA8 ASH1L MACROD1 MYO1B ADCY3 JMJD1C SLFN12L DSTYK LRP5 NYAP1 ARHGAP45 MYBL2 | 4.51e-04 | 1045 | 156 | 15 | EFO_0007986 |
| Disease | Autistic Disorder | 4.97e-04 | 261 | 156 | 7 | C0004352 | |
| Disease | insulin measurement | 5.69e-04 | 267 | 156 | 7 | EFO_0004467 | |
| Disease | sphingomyelin measurement | 7.21e-04 | 278 | 156 | 7 | EFO_0010118 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 7.40e-04 | 364 | 156 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | triacylglycerol 58:10 measurement | 7.69e-04 | 34 | 156 | 3 | EFO_0010437 | |
| Disease | Profound Mental Retardation | 8.82e-04 | 139 | 156 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 8.82e-04 | 139 | 156 | 5 | C0025363 | |
| Disease | Mental deficiency | 8.82e-04 | 139 | 156 | 5 | C0917816 | |
| Disease | Autism Spectrum Disorders | 1.09e-03 | 85 | 156 | 4 | C1510586 | |
| Disease | Inherited focal segmental glomerulosclerosis | 1.22e-03 | 10 | 156 | 2 | cv:CN327126 | |
| Disease | Focal segmental glomerulosclerosis | 1.22e-03 | 10 | 156 | 2 | cv:C0017668 | |
| Disease | response to bisphosphonate, osteonecrosis | 1.22e-03 | 10 | 156 | 2 | EFO_0004259, EFO_0009958 | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 1.48e-03 | 11 | 156 | 2 | cv:CN043612 | |
| Disease | urate measurement, bone density | CNTN4 CASP8AP2 TBC1D2 OGDH ERBIN CASZ1 PTPRN2 LZTS1 ANKRD11 UTRN | 1.75e-03 | 619 | 156 | 10 | EFO_0003923, EFO_0004531 |
| Disease | Huntington Disease, Late Onset | 1.77e-03 | 12 | 156 | 2 | C0393574 | |
| Disease | Akinetic-Rigid Variant of Huntington Disease | 1.77e-03 | 12 | 156 | 2 | C0751207 | |
| Disease | Juvenile Huntington Disease | 1.77e-03 | 12 | 156 | 2 | C0751208 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.77e-03 | 12 | 156 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 1.99e-03 | 100 | 156 | 4 | C0010606 | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 2.08e-03 | 13 | 156 | 2 | cv:C4273714 | |
| Disease | obsolete_red blood cell distribution width | CCDC69 CCDC91 FLT3 SAMD9 KAT5 HEMGN BCKDHA PRC1 ITFG1 SLFN12L DSTYK FBXO7 LRP5 AFDN FRMD5 MYBL2 | 2.13e-03 | 1347 | 156 | 16 | EFO_0005192 |
| Disease | Influenza | 2.65e-03 | 52 | 156 | 3 | C0021400 | |
| Disease | neutrophil count | CCDC69 FLT3 MYO1E RBBP8 ASH1L MYO1B JMJD1C CASZ1 PLA2R1 SLFN12L TIE1 DSTYK NBPF10 ANKRD11 ARHGAP45 HTT | 2.75e-03 | 1382 | 156 | 16 | EFO_0004833 |
| Disease | Autosomal recessive primary microcephaly | 2.79e-03 | 15 | 156 | 2 | cv:C3711387 | |
| Disease | Acute Cerebrovascular Accidents | 2.95e-03 | 54 | 156 | 3 | C0751956 | |
| Disease | mean platelet volume | MYO1E NUMA1 CASR ACTN4 PFKP PRC1 ITGB3 JMJD1C DSTYK GYS2 ANKRD11 ARHGAP45 HTT | 3.08e-03 | 1020 | 156 | 13 | EFO_0004584 |
| Disease | lymphocyte measurement | 3.51e-03 | 117 | 156 | 4 | EFO_0803546 | |
| Disease | Huntington Disease | 3.59e-03 | 17 | 156 | 2 | C0020179 | |
| Disease | Van Buchem disease | 3.59e-03 | 17 | 156 | 2 | C0432272 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 3.59e-03 | 17 | 156 | 2 | cv:C0270914 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.30e-03 | 200 | 156 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | Cerebrovascular accident | 4.36e-03 | 62 | 156 | 3 | C0038454 | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 4.48e-03 | 19 | 156 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | triglyceride measurement, body mass index | 4.48e-03 | 19 | 156 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | lymphocyte count | CCDC69 FLT3 DNAH10 RBBP8 MACROD1 UROC1 JMJD1C CASZ1 SLFN12L CCDC66 CDK13 PRKAA2 ANKRD11 NDUFAF6 ARHGAP45 HTT | 4.79e-03 | 1464 | 156 | 16 | EFO_0004587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EFKRLHHERWKREGK | 296 | A8MVM7 | |
| KREEHQRWYEKEKAR | 1411 | P55196 | |
| VHHRKKLERDKEWIQ | 451 | Q5W0A0 | |
| WREQVLRHIEAKKLE | 1196 | Q96RT1 | |
| WEKIRQKQEEVKHTS | 2371 | Q9NR48 | |
| KDVHKRILQIEWEHK | 1491 | Q8NDM7 | |
| KREKHREKWRDEKER | 1461 | Q6UB99 | |
| TLRNVEKVWKAEQKH | 16 | Q9NXE8 | |
| EKVWKAEQKHEAERK | 21 | Q9NXE8 | |
| KDLWTKLKECHDREV | 21 | Q99708 | |
| EFKHEKSWRRQKISG | 271 | P30939 | |
| WHIKKHEKAERRAAN | 1261 | Q86V15 | |
| SIRKQWRILKSHVEK | 341 | Q9Y2D8 | |
| RATIKDIREHEWFKQ | 256 | P54646 | |
| DIKKVEAWQVLKHLR | 451 | P41180 | |
| RKQLWDVAHSVKEKF | 386 | P54840 | |
| SKWEKVQQLVPKRDH | 621 | O43707 | |
| WRHEDKEENARKIRT | 841 | Q8IWV2 | |
| SREVHKAEWRIKEQK | 931 | Q9UDT6 | |
| KEARKEILKIHTRDW | 601 | Q6PL18 | |
| AKREHAERRKSWLQK | 2136 | Q8TDJ6 | |
| RIKWHRKQLLEDIQK | 21 | Q9UIA0 | |
| KPKSVVKDQDHWRRS | 371 | Q9UKL3 | |
| DCHELWSKKRRRQKQ | 1016 | Q14004 | |
| KVWRRFHQRKETEKL | 216 | Q86XH1 | |
| VRKDRHLWKDVGERQ | 796 | Q8IZT6 | |
| RAFREWHLRKQAKEE | 1451 | Q8IZT6 | |
| RRLHQRSVSKEKWVE | 231 | Q9UKP4 | |
| SREWKGHKEKHREAL | 101 | Q7Z4T9 | |
| TRILQQHEEEKKKWA | 61 | A6NI79 | |
| KEERKRWQATLDKHL | 826 | P15918 | |
| WSKEERKQHLVRAKE | 941 | Q6ZMN7 | |
| RTEVRKALAKDKEWQ | 96 | Q9UFN0 | |
| EDHLKNKNRLEKEWE | 736 | Q92932 | |
| ERKEKEIQWETRLFH | 701 | Q96SU4 | |
| QKEHKILREAAIRKW | 301 | Q8N9V6 | |
| IHQREIEAKKEFDKW | 241 | Q8IYY4 | |
| EIQKTEWKRKVKELH | 331 | Q8IYY4 | |
| VKQWRDQAEKFRKEH | 441 | Q86T65 | |
| EHEKRRKEIKEAWHR | 376 | Q92619 | |
| RKEIKEAWHRAQRKL | 381 | Q92619 | |
| HKKALEERECELLWK | 371 | Q2Q1W2 | |
| QHERLVWKEEKEKVI | 526 | Q9Y250 | |
| LHTSRVLKEDKERWE | 336 | P49137 | |
| IQKLKKDRWQERHIL | 236 | Q09161 | |
| SLEKDRERWRKHLKG | 2166 | Q8IWI9 | |
| KTPKDWVRQHRKEEK | 126 | Q9UHH9 | |
| HRRELNDVISIWEKK | 1036 | Q13439 | |
| LKDWHDKEAIRRDAQ | 71 | Q86SR1 | |
| KARARVEKWNADHSK | 261 | Q8TBA6 | |
| KKAWLTRHSEEDKNT | 1551 | Q15652 | |
| TDWQRRSIERVHKVK | 561 | O75197 | |
| EWVTHERLDLKKIQF | 56 | Q92993 | |
| REKEFQHKLVRIWEE | 31 | Q96DD0 | |
| VIKKNKWERDEDSLH | 556 | P0C7V8 | |
| KVEVLERELAWLKEH | 221 | Q9NVF9 | |
| WSKEERKQHLIRARE | 676 | Q76G19 | |
| KKQTDFEHRIPKEQW | 736 | Q01813 | |
| IELWKAVKRHNLTKR | 136 | Q330K2 | |
| ARKRAKQFHEAWKKL | 2676 | O94854 | |
| SVIRALWETRVKKHK | 11 | Q9BYS8 | |
| KRWAERAHKVVEIKS | 181 | O60487 | |
| REQEKKMWRQEEKIH | 421 | A8MZA4 | |
| WRQKEKMHEQEEKIR | 466 | A8MZA4 | |
| DQEKLRKHEEKMWRQ | 246 | A0A1B0GV03 | |
| WRQEEKIHEQEKIRE | 376 | H0YM25 | |
| HEQEEKIRKQEEKVW | 421 | H0YM25 | |
| KWIEHSKLREINFKI | 96 | Q9H1C3 | |
| KRRHIPEESTNKWKQ | 476 | Q5XXA6 | |
| CDDKRHKDIWSREKT | 576 | Q9H3R1 | |
| DQVEAKWVEVKSKRR | 131 | Q9ULB1 | |
| SLRNKEVKEAARKVW | 291 | Q8NGT2 | |
| IVKEIHEQLKAFWRE | 431 | P29728 | |
| KQHADRLDRKWKRKN | 496 | O94880 | |
| EKTEDLWLRVRKDHA | 616 | Q6XUX3 | |
| RKRKAEVHEKETSQW | 41 | Q9BXL5 | |
| KNHWEELSKKTADRQ | 4886 | Q9UPN3 | |
| EAAKHHKDVLRLIWK | 96 | Q15646 | |
| QAEWREEVKKHFEKI | 426 | O43283 | |
| TREHVQKKAAEWKIK | 161 | Q9NRN9 | |
| KEAVKEESIKRHKWN | 701 | O60313 | |
| ARSKDEKILHIKHWL | 571 | Q02218 | |
| KREKFHRTWTEIFKE | 706 | P36888 | |
| DKQRHWLEFTKSVVK | 66 | Q7Z6J6 | |
| KERKWNLTEVKELHE | 21 | A4FU69 | |
| NLVIKDKFIRRWVHK | 801 | Q8NFZ0 | |
| HKENEDKWKRLSRQI | 1596 | P42858 | |
| KVTIRTDNKDWRIHV | 251 | Q9NWB7 | |
| INWVKHAKKEREESL | 201 | Q53G59 | |
| DCLKNKDKRIERWHT | 386 | Q14184 | |
| REKRKIIAEEKHKEW | 181 | Q96HJ3 | |
| KLRKAHVIWKKENEV | 311 | O95727 | |
| RKNLEKAHAEERELW | 326 | Q7Z6B0 | |
| ERELWKTEHAKDQEK | 336 | Q7Z6B0 | |
| DWKELYRKRHIQRKE | 391 | Q9Y3I1 | |
| EKRREALWEKNTHLE | 651 | Q9BV73 | |
| HEKEVNQLREKWEKE | 851 | Q9BV73 | |
| FLKQKWALHEVRVRK | 361 | Q96RY5 | |
| QETESKLRWHLVKKE | 766 | A2RUB6 | |
| KLEKLKERIRKQWEH | 281 | Q5VT06 | |
| ELAWLEHQKKHLRDK | 1716 | Q5VT06 | |
| IQRIEKEKWHRLEAK | 46 | Q6TDU7 | |
| KEKWHRLEAKDLERR | 51 | Q6TDU7 | |
| TLFLWKIEVHDQKER | 866 | O60266 | |
| KEKWKHARVKEREHE | 106 | Q9UQ88 | |
| WREEVKLHFEKIKSE | 386 | Q12852 | |
| TLREWLEQHKDKVDR | 286 | Q9BQ69 | |
| WKLLITIHDRKEFAK | 741 | P05106 | |
| IELKSEALKDRHWKQ | 1401 | Q14204 | |
| KVHLREEKVEVWFKN | 196 | P56915 | |
| RRKEDEVEEWQHRAK | 436 | P15311 | |
| KEARKWATRVAREHK | 326 | O94868 | |
| ERGKAEWHKLLIEER | 1191 | A2RUR9 | |
| LDLKNEALRDRHWKE | 1336 | Q8IVF4 | |
| TWKERTLKREAHKQV | 2586 | Q02224 | |
| HRSNVIWEIKVLRKE | 166 | P42702 | |
| EEQEKAWRKQSRRKV | 376 | P12694 | |
| RTKVQDHSKAEDEWK | 1196 | Q14980 | |
| LQVWKKHFEARKEEK | 241 | Q9HAU5 | |
| RKTKLEWRQHKEEEA | 6 | Q6ZVC0 | |
| DNKDWHRKSKEADRQ | 756 | Q9UPX6 | |
| RWAGSKKEKHVRFEV | 201 | Q96CW9 | |
| WEKFQEEAKNRDHRK | 311 | P26639 | |
| RKKERGREEKCVWKH | 206 | Q5H9L4 | |
| EIKALQLWKEIETRH | 31 | O96033 | |
| VHAEKLKWLNRTELE | 2131 | P46939 | |
| AWQARKELHKAVRKV | 91 | Q96JX3 | |
| RWRELAEKLAKVSKQ | 856 | Q9P0V3 | |
| SFDWKLKAHILRDKV | 126 | Q8N3T6 | |
| KKAHENWLKARAAER | 1596 | Q5JRA6 | |
| RFWKLRQEIVEHVKA | 261 | Q9C0I9 | |
| AVDIGRHRWDQVKKE | 561 | Q3BBV2 | |
| AVDIGRHRWDQVKKE | 596 | P0DPF3 | |
| AVDIGRHRWDQVKKE | 596 | Q6P3W6 | |
| AVDIGRHRWDQVKKE | 596 | Q86T75 | |
| AVDIGRHRWDQVKKE | 256 | Q5TI25 | |
| VDIGRHRWDQVKKED | 326 | Q8N660 | |
| VDIGRHRWDQVKKED | 326 | A0A087WUL8 | |
| AVDIGRHRWDQVKKE | 256 | B4DH59 | |
| DQHWLEKKDVVGRAR | 116 | P0C7V7 | |
| KITKAREWFHRTVKI | 856 | O94906 | |
| WRKTREDQHVKERTA | 351 | Q96NR3 | |
| WKDLLEARLIKHQDE | 586 | Q5K651 | |
| KVKWTHEEDEQLRAL | 31 | P10244 | |
| DHANREAELKKKWVE | 51 | Q9NVN8 | |
| ERRKHKKHPTEDWEK | 1301 | O14594 | |
| LKARIELWEQEHSKA | 406 | O43663 | |
| KKEVEHYRKRWREIN | 721 | Q8IY81 | |
| GWKKELEDLVRREHA | 336 | Q8IXJ6 | |
| AVKRVFLSEWKEHKV | 91 | Q9H5K3 | |
| KLQKEEKTWHEALRS | 391 | Q13018 | |
| KRATIKDIREHEWFK | 266 | Q13131 | |
| LTADKRDDNKWIKLH | 2061 | Q8N3C0 | |
| KIDVNDWKVNTRLKH | 631 | Q9HAU4 | |
| HWLKKTEEEASRGIK | 41 | Q7Z5L4 | |
| KKHDKILETSRGADW | 161 | Q9UBH6 | |
| GQRDRKAEHWKHKKE | 481 | Q96AQ6 | |
| HVKDNRVKQLTEKEW | 341 | Q6IEE8 | |
| NKAWERLEKAEHERE | 396 | O15020 | |
| EVDKAALEKRHRQGW | 271 | Q96N76 | |
| GLWERQAREHSERKK | 216 | P08294 | |
| ARVHKEKQTDVIWKS | 146 | P35590 | |
| RWEKEKHEDGVKWRQ | 41 | Q969P6 | |
| WTEKHARQKQKADEE | 146 | Q9NPD8 | |
| KQQDETHKLESWLRK | 371 | Q9NXF1 | |
| EKRNQKWRSLEKRAD | 276 | Q8NEG5 | |
| EIKKKIHDFDCQWRD | 136 | Q09FC8 | |
| KLRDKAKELWETLHQ | 206 | P45378 | |
| EKAVKWSQQVERHRE | 181 | Q5BJD5 | |
| QRKQRHWEKIVAAKK | 66 | Q6PF06 | |
| GILHWQEKKADDREK | 586 | Q8TB96 | |
| KRLKWIHKALEQRKE | 241 | P17480 | |
| LRDHTKKELDSWKIV | 216 | A3KMH1 | |
| VKENNLEEHWRKAKE | 396 | Q8NA31 | |
| KTVLRDEIIAWHKKT | 3771 | Q9Y4A5 | |
| HSSDNKRWRKKIIEK | 116 | Q9HBA0 | |
| HQVTKIWRKVAEKEK | 476 | Q9BYX2 | |
| VREKELKDLQWEHEV | 316 | O95995 | |
| VRSKELEQRKRWVKA | 661 | Q8N5Q1 | |
| LKEEARRKHAVAVIW | 831 | O43795 | |
| ETKKPRDWEESRVKH | 591 | Q12965 |